Developer docs
API playgroundTry for free, no card

Search company profiles

Calmoseptine

Full company profile

uuid000bz3g

Namestring
Calmoseptine
Legal namestring
Calmoseptine, Inc.
Company typeenum
Private
Founded yearint
1987
Descriptiontext

Calmoseptine, Inc. is a privately held U.S. pharmaceutical company headquartered in Huntington Beach, California, that manufactures and distributes a single product — Calmoseptine Ointment, a multipurpose zinc oxide-based moisture barrier ointment for skin protection, soothing, and healing. The product is indicated primarily for Incontinence-Associated Dermatitis (IAD) in children over 12 and adults with urinary and/or fecal incontinence, with a peer-reviewed clinical study (NCT02080247, published in the WCET journal) demonstrating significantly superior healing rates versus Desitin (25% vs 7.7% complete healing at day 6, p=0.009). The ointment is sold over-the-counter without prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets) at suggested retail prices of $5.69-$8.75 for the 4 oz tube.

The company's revenue model is single-stream OTC product sales distributed through four primary channels: major U.S. retail pharmacy chains (CVS, Walgreens, Walmart, Costco), mail-order and e-commerce platforms (Amazon, Allegro Medical, Express Medical Supply, HDIS, Walgreens online), direct company sales (minimum 1 case), and federal government procurement under Federal Supply Schedule contract No: 36F79721D0024 (valid 12-01-2020 through 11-30-2025). Internationally, distribution is handled by exclusive partners including Metro Drug Inc. in the Philippines, Zuellig Pharma in Thailand and Malaysia, and Pharmaceutical Resource Limited in Canada, with the product available across 10+ countries and brochures in 16 languages. Customer segments span individual consumers, healthcare professionals (nurses, pharmacists, physicians reached via major healthcare tradeshows), and institutional buyers (hospitals, nursing homes, long-term care facilities). The company has 11-50 employees, has held the #1 Pharmacist Recommended Brand ranking for incontinence-related skin protectants for four consecutive years from U.S. News & World Report and Pharmacy Times, and is recognized as a small business under federal contracting rules. Revenue figures are not publicly disclosed.

Short descriptiontext

Calmoseptine, Inc. is a privately held U.S. pharmaceutical manufacturer of a single OTC zinc oxide-based multipurpose moisture barrier ointment for Incontinence-Associated Dermatitis, distributed through major U.S. retail pharmacies, mail-order, federal supply, and exclusive international partners across 10+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHuntington Beach, United States
HQ citystring
Huntington Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
moisture barrier ointment, incontinence skin care, wound healing ointment, topical zinc oxide, dermatitis treatment
Industry2 codes
PRIMARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYCRABAJAC
Diapering & Wipes (Diaper Creams, Wipes)
NAICS code1 code
  • Toilet Preparation Manufacturing325620
SIC code1 code
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
Product category
Topical Skin Care and Wound Healing Ointments
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Product Sales
TypeOne Time License
Description

Calmoseptine generates revenue through direct sales of its Calmoseptine Ointment product to consumers via retail pharmacies, mail order, and direct purchases from the company. The product is available without prescription at retail prices ranging from $5.69-$8.75 for consumer-sized tubes.

calmoseptineointment.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Supply Chain, Marketing or Sales, Personnel
Pricing details4 tiers
14 oz Tube - Most popular and cost-effective
ModelUnit PricingBilling cadencePay-as-you-go
Notes

As low as $5.69 for 4 oz tube in stores. Suggested retail price $8.75 for 4 oz tube. Direct company pricing: $82.80 per case (12 tubes) at $6.90 per tube.

calmoseptineointment.com
22.5 oz Tube
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Suggested retail price $7.00. Direct company pricing: $69.00 per case (12 tubes) at $5.75 per tube.

calmoseptineointment.com
31/8 oz Sample Packet (144 count box)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Gross of 144pc $86.40. Available only in boxes of 144.

calmoseptineointment.com
4Federal Supply Schedule Pricing
ModelUnit PricingBilling cadenceMulti-year contract
Notes

NDC #0799-0001-02 (2.5 oz tube) - 12 tubes per case. NDC #0799-0001-04 (4.0 oz tube) - 12 tubes per case. NDC #0799-0001-06 (20g tube) - 12 tubes per case. NDC #0799-0001-05 (1/8 oz sample packet) - 1,000 per case. Contract Period: 12-01-2020 Through 11-30-2025. Small business designation.

calmoseptineointment.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Calmoseptine manufactures and sells Calmoseptine® Ointment, a multipurpose moisture barrier ointment containing zinc oxide that protects, soothes, and promotes healing of skin irritations. The product is sold over-the-counter without a prescription in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets, and is primarily used for the prevention and treatment of Incontinence Associated Dermatitis (IAD) in children over 12 years and adults.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 25% of patients completely healed at day 6 with Calmoseptine vs 7.7% with Desitin (p=0.009)
+1 more record
Product overview1 text field

Calmoseptine is a single-product pharmaceutical company offering Calmoseptine® Ointment, a multipurpose moisture barrier ointment. The product is available over-the-counter without a prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets). It is manufactured in Huntington Beach, California and sold through pharmacies, major retailers (CVS, Walgreens, Walmart, Costco), and direct mail order channels.

Product and service1 record
1Calmoseptine® Ointment
CategoryTopical Skin Care and Wound Healing Ointments
Description

A zinc oxide-based multipurpose moisture barrier ointment that protects, soothes, and promotes healing of skin irritations, available over-the-counter in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets. Used by individuals aged 12 and older, healthcare professionals, and institutional buyers for the prevention and treatment of Incontinence Associated Dermatitis (IAD) and general skin protection.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor for Calmoseptine in the Philippines. Product available in all Mercury drug branches and most drugstores nationwide.

2Zuellig Pharma Ltd. (Thailand)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Authorized importer and distributor for Thailand. Contact: Chutima Chinhiran, Product Manager. Available in 3.5g sachets.

calmoseptineointment.com
3Zuellig Pharma Sdn. Bhd. (Malaysia)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Authorized importer and distributor for Malaysia. Contact: Siti Nor Wana Saari, Sales/Product Manager.

calmoseptineointment.com
4Pharmaceutical Resource Limited (Canada)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Canadian distributor contact. Located at 10 Turnberry Court, St. Thomas, Ontario. Toll Free: 877-741-9295.

calmoseptineointment.com
Strategic tierMinorTypeOthers
Description

Calmoseptine, Inc. supports charitable causes including the American Red Cross.

Strategic tierMinorTypeOthers
Description

Calmoseptine, Inc. supports charitable causes including the World Surgical Foundation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Johnson & Johnson's Desitin is the most direct competitor, a leading zinc oxide diaper rash paste and skin protectant explicitly benchmarked against Calmoseptine in the published WCET clinical trial — making it the closest head-to-head comparable.

TypeDirect peer
Description

Boudreaux's Butt Paste is a leading OTC zinc oxide-based diaper rash and skin protectant ointment competing for the same pediatric and adult incontinence skin care shelf space at major U.S. retailers.

3Triple Paste
TypeDirect peer
Description

Triple Paste is a competitor zinc oxide-based skin protectant marketed for diaper rash and incontinence-related skin irritation, occupying the same OTC pharmacy channel and consumer use cases as Calmoseptine.

4A+D (Bayer)
TypeDirect peer
Description

A+D Original Ointment is a long-standing zinc oxide and petrolatum-based skin protectant competing directly in the diaper rash and adult incontinence skin barrier category.

5Aquaphor (Beiersdorf)
TypeDirect peer
Description

Aquaphor Healing Ointment is a Beiersdorf-owned skin protectant widely recommended by pharmacists and dermatologists for barrier protection, directly competing for shelf space and consumer skin protectant dollars.

TypeDirect peer
Description

Balmex is an OTC zinc oxide-based diaper rash and skin protectant cream with multi-decade heritage competing in the same OTC incontinence and diaper rash use cases as Calmoseptine.

7Medline Remedy (Medline Industries)
TypeDirect peer
Description

Medline's Remedy skincare line includes moisture barrier ointments sold primarily into hospitals, long-term care, and home health — directly competing for the same institutional channel as Calmoseptine.

TypeBroad incumbent
Description

Coloplast is a global continence care leader offering skin barriers, barrier creams, and related products through its ostomy and continence franchises — a much larger incumbent competing for both consumer and institutional incontinence skin care spend.

TypeBroad incumbent
Description

ConvaTec is a diversified wound and skin care company offering barrier products, ostomy accessories, and incontinence skin care — competing for institutional formularies and overlapping use cases with Calmoseptine.

TypeBroad incumbent
Description

Smith & Nephew's Advanced Wound Management portfolio includes skin protectants and barrier products sold into hospitals and long-term care — competing for the same institutional skin protectant budget as Calmoseptine.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calmoseptine

Topical Skin Care and Wound Healing Ointmentscalmoseptineointment.com

Calmoseptine, Inc. is a privately held U.S. pharmaceutical manufacturer of a single OTC zinc oxide-based multipurpose moisture barrier ointment for Incontinence-Associated Dermatitis, distributed through major U.S. retail pharmacies, mail-order, federal supply, and exclusive international partners across 10+ countries.

What Calmoseptine does

Calmoseptine, Inc. is a privately held U.S. pharmaceutical company headquartered in Huntington Beach, California, that manufactures and distributes a single product — Calmoseptine Ointment, a multipurpose zinc oxide-based moisture barrier ointment for skin protection, soothing, and healing. The product is indicated primarily for Incontinence-Associated Dermatitis (IAD) in children over 12 and adults with urinary and/or fecal incontinence, with a peer-reviewed clinical study (NCT02080247, published in the WCET journal) demonstrating significantly superior healing rates versus Desitin (25% vs 7.7% complete healing at day 6, p=0.009). The ointment is sold over-the-counter without prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets) at suggested retail prices of $5.69-$8.75 for the 4 oz tube.

The company's revenue model is single-stream OTC product sales distributed through four primary channels: major U.S. retail pharmacy chains (CVS, Walgreens, Walmart, Costco), mail-order and e-commerce platforms (Amazon, Allegro Medical, Express Medical Supply, HDIS, Walgreens online), direct company sales (minimum 1 case), and federal government procurement under Federal Supply Schedule contract No: 36F79721D0024 (valid 12-01-2020 through 11-30-2025). Internationally, distribution is handled by exclusive partners including Metro Drug Inc. in the Philippines, Zuellig Pharma in Thailand and Malaysia, and Pharmaceutical Resource Limited in Canada, with the product available across 10+ countries and brochures in 16 languages. Customer segments span individual consumers, healthcare professionals (nurses, pharmacists, physicians reached via major healthcare tradeshows), and institutional buyers (hospitals, nursing homes, long-term care facilities). The company has 11-50 employees, has held the #1 Pharmacist Recommended Brand ranking for incontinence-related skin protectants for four consecutive years from U.S. News & World Report and Pharmacy Times, and is recognized as a small business under federal contracting rules. Revenue figures are not publicly disclosed.

Calmoseptine firmographics

Firmographics
Name
Calmoseptine
Legal name
Calmoseptine, Inc.
Website
https://calmoseptineointment.com
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
11–50 employees
Short description
Calmoseptine, Inc. is a privately held U.S. pharmaceutical manufacturer of a single OTC zinc oxide-based multipurpose moisture barrier ointment for Incontinence-Associated Dermatitis, distributed through major U.S. retail pharmacies, mail-order, federal supply, and exclusive international partners across 10+ countries.
Ownership category
akta.pro rank

Calmoseptine industry classification

Industry
Product category
Topical Skin Care and Wound Healing Ointments
NAICS
Toilet Preparation Manufacturing (325620)
SIC
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
akta.pro industry
PRIMARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYCRABAJAC
Diapering & Wipes (Diaper Creams, Wipes)

Keywords

  • Moisture barrier ointment
  • Incontinence skin care
  • Wound healing ointment
  • Topical zinc oxide
  • Dermatitis treatment

Where Calmoseptine is headquartered

Location

Headquarters

HQ city
Huntington Beach
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Calmoseptine business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Marketing or Sales, Personnel

Revenue model

  1. Product Sales: Calmoseptine generates revenue through direct sales of its Calmoseptine Ointment product to consumers via retail pharmacies, mail order, and direct purchases from the company. The product is available without prescription at retail prices ranging from $5.69-$8.75 for consumer-sized tubes.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-go4 oz Tube - Most popular and cost-effective
Unit PricingPay-as-you-go2.5 oz Tube
Unit PricingPay-as-you-go1/8 oz Sample Packet (144 count box)
Unit PricingMulti-year contractFederal Supply Schedule Pricing

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Calmoseptine product offering

Product offering

Core offering

Calmoseptine manufactures and sells Calmoseptine® Ointment, a multipurpose moisture barrier ointment containing zinc oxide that protects, soothes, and promotes healing of skin irritations. The product is sold over-the-counter without a prescription in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets, and is primarily used for the prevention and treatment of Incontinence Associated Dermatitis (IAD) in children over 12 years and adults.

Product overview

Calmoseptine is a single-product pharmaceutical company offering Calmoseptine® Ointment, a multipurpose moisture barrier ointment. The product is available over-the-counter without a prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets). It is manufactured in Huntington Beach, California and sold through pharmacies, major retailers (CVS, Walgreens, Walmart, Costco), and direct mail order channels.

Differentiator

Problem solved

Functional benefit

Products and services

  • Calmoseptine® Ointment A zinc oxide-based multipurpose moisture barrier ointment that protects, soothes, and promotes healing of skin irritations, available over-the-counter in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets. Used by individuals aged 12 and older, healthcare professionals, and institutional buyers for the prevention and treatment of Incontinence Associated Dermatitis (IAD) and general skin protection.

Quantifiable outcome

  • 25% of patients completely healed at day 6 with Calmoseptine vs 7.7% with Desitin (p=0.009)
  • +1 more outcomes

Companies that use Calmoseptine

Customer profile

Segments3 records

Ideal customer profiles3 records

Calmoseptine technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Calmoseptine partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Metro Drug Inc.coreChannel Partner/ Reseller/ DistributorExclusive distributor for Calmoseptine in the Philippines. Product available in all Mercury drug branches and most drugstores nationwide.
  • Zuellig Pharma Ltd. (Thailand)coreChannel Partner/ Reseller/ DistributorAuthorized importer and distributor for Thailand. Contact: Chutima Chinhiran, Product Manager. Available in 3.5g sachets.
  • Zuellig Pharma Sdn. Bhd. (Malaysia)coreChannel Partner/ Reseller/ DistributorAuthorized importer and distributor for Malaysia. Contact: Siti Nor Wana Saari, Sales/Product Manager.
  • Pharmaceutical Resource Limited (Canada)coreChannel Partner/ Reseller/ DistributorCanadian distributor contact. Located at 10 Turnberry Court, St. Thomas, Ontario. Toll Free: 877-741-9295.
  • American Red CrossminorOthersCalmoseptine, Inc. supports charitable causes including the American Red Cross.
  • World Surgical FoundationminorOthersCalmoseptine, Inc. supports charitable causes including the World Surgical Foundation.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Calmoseptine competitors and assessment

Company assessment

Direct peers

  • Desitin (Johnson & Johnson): Johnson & Johnson's Desitin is the most direct competitor, a leading zinc oxide diaper rash paste and skin protectant explicitly benchmarked against Calmoseptine in the published WCET clinical trial — making it the closest head-to-head comparable.
  • Boudreaux's Butt Paste: Boudreaux's Butt Paste is a leading OTC zinc oxide-based diaper rash and skin protectant ointment competing for the same pediatric and adult incontinence skin care shelf space at major U.S. retailers.
  • Triple Paste: Triple Paste is a competitor zinc oxide-based skin protectant marketed for diaper rash and incontinence-related skin irritation, occupying the same OTC pharmacy channel and consumer use cases as Calmoseptine.
  • A+D (Bayer): A+D Original Ointment is a long-standing zinc oxide and petrolatum-based skin protectant competing directly in the diaper rash and adult incontinence skin barrier category.
  • Aquaphor (Beiersdorf): Aquaphor Healing Ointment is a Beiersdorf-owned skin protectant widely recommended by pharmacists and dermatologists for barrier protection, directly competing for shelf space and consumer skin protectant dollars.
  • Balmex (Emerson Healthcare): Balmex is an OTC zinc oxide-based diaper rash and skin protectant cream with multi-decade heritage competing in the same OTC incontinence and diaper rash use cases as Calmoseptine.
  • Medline Remedy (Medline Industries): Medline's Remedy skincare line includes moisture barrier ointments sold primarily into hospitals, long-term care, and home health — directly competing for the same institutional channel as Calmoseptine.

Broad incumbents

  • Coloplast: Coloplast is a global continence care leader offering skin barriers, barrier creams, and related products through its ostomy and continence franchises — a much larger incumbent competing for both consumer and institutional incontinence skin care spend.
  • ConvaTec: ConvaTec is a diversified wound and skin care company offering barrier products, ostomy accessories, and incontinence skin care — competing for institutional formularies and overlapping use cases with Calmoseptine.
  • Smith & Nephew: Smith & Nephew's Advanced Wound Management portfolio includes skin protectants and barrier products sold into hospitals and long-term care — competing for the same institutional skin protectant budget as Calmoseptine.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Calmoseptine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calmoseptine leadership team

Management profile

Number of profiles

Calmoseptine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calmoseptine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calmoseptine

What does Calmoseptine do?

Calmoseptine manufactures and sells Calmoseptine® Ointment, a multipurpose moisture barrier ointment containing zinc oxide that protects, soothes, and promotes healing of skin irritations. The product is sold over-the-counter without a prescription in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets, and is primarily used for the prevention and treatment of Incontinence Associated Dermatitis (IAD) in children over 12 years and adults.

Is Calmoseptine a public or private company?

Calmoseptine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Calmoseptine founded?

Calmoseptine was founded in 1987. It employs 11 to 50 people.

Where is Calmoseptine based?

Calmoseptine is headquartered in Huntington Beach, United States, in the North America region.

How does Calmoseptine make money?

One revenue line is on record: product Sales.

Who are Calmoseptine's main competitors?

Direct peers on record are Desitin (Johnson & Johnson), Boudreaux's Butt Paste, Triple Paste, A+D (Bayer), Aquaphor (Beiersdorf), Balmex (Emerson Healthcare) and Medline Remedy (Medline Industries). Broad incumbents are Coloplast, ConvaTec and Smith & Nephew.

Does Calmoseptine have an API?

No public API is recorded for Calmoseptine.

What industry is Calmoseptine in?

Calmoseptine's product category is Topical Skin Care and Wound Healing Ointments. Its primary akta.pro industry code is CRABAAAG, Sensitive Skin & Barrier Repair, with a secondary code of CRABAJAC, Diapering & Wipes (Diaper Creams, Wipes). Its NAICS code is 325620 and its SIC code is 2840.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales